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ABSTRACT
Background: Infection is an invasion of an organism’s body tissues by disease-causing agents, their multiplication, and 
the reaction of host tissues to the infectious agents and the toxins they produce. Patients with renal compromised states 
are more susceptible to infection than normal individuals. In the pre-dialysis era, about 45% of patients with the renal 
compromised state suffering from infection required hospitalization, while a total of about 78% of the enrolled subjects 
needed hospitalization. It was assumed that the debility caused by the uremic state increased the risk of infection, and 
the reversal of uremia would reduce the risk of infection.
Aim: The main aim of the study is to report the incidence of infectious diseases in patients with renal compromised 
state and appropriate measures to be considered to control infectious conditions.
Materials and Methods: The study was carried out as prospective and cross-sectional studies. During the study period, 
a total of 195 subjects were examined with the renal compromised state, of which 108 subjects were suffering from 
infectious co-morbidity, and were enrolled based on inclusion and exclusion criteria, which includes in-patients, out-
patients, and patients on regular dialysis.
Results: This shows the percentage prevalence of infections in patients with the renal compromised state is 55.38. 
Patients were found to show various infectious states.
Conclusion: The conclusion shows the probability of encountering a subject with renal compromised state along with 
co-morbid infection is 0.55. Evidence-based international guidelines are of great value and are instrumental in helping 
reduce health-care-associated infections.
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INTRODUCTION
Renal disease or renal compromised state is the condition 
when a patient’s kidneys begin to show a gradual or drastic 
decline in the glomerular filtration rate (GFR) value and 
thereby kidneys lose their ability to filter wastes from the 
blood.
During this study, the various renal compromised 
states included were acute and chronic kidney disease, 
nephritis, nephropathy, nephrotic syndrome, and subjects 
undergoing dialysis. The prime co-morbidities which 
include infections caused by bacteria, viruses, or fungi 
were considered in this study.
Febrile conditions (temperature ≥100° F) that 
developed during dialysis or in the span of about 48 h 
post-dialysis were also considered during this study; 
however, the patient may develop fever state due to non-
infectious causes as well, which includes broader variation 
in temperature between dialyzing fluid and body fluid, 
increased/decreased rate of filtration and flow by dialyzing 
machine, continuous/prolonged use of dialysis machine/
dialysate membrane, cooler temperature maintained in 
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rooms where dialysis is being carried, using of ethylene 
oxide gas for sterilization of dialysis machine, tubes or 
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dialysis room may lead to fever and anaphylactic shock 
in certain population group allergic to it. Therefore, the 
confirmation of the infectious state relied on laboratory 
findings of the subject.
According to one of the recent study conducted by 
Aakanksha B. (September 2018), the number of Indians 
that suffer from chronic kidney ailments has doubled in 
the past decade and about 8–10% of the adult population 
suffers from some or the other form of kidney diseases. 
Furthermore, it is believed that patients suffering from 
renal compromised states are more easily prone to acquire 
infectious diseases than normal person. Hence, this study 
was conducted to determine the incidence of infectious 
diseases in patients suffering from renal compromised 
state.[1-10]
MATERIALS AND METHODS
All relevant and necessary data for this study were 
collected from patient case notes, treatment charts, dialysis 
notes, laboratory reports, interviewing patient/patient 
caretaker, and interviewing healthcare professionals. The 
data collection for this study was done in the following 
hospitals:
•	 Hyderabad Kidney and Laparoscopy Centre, 
Malakpet, Telangana
•	 Malla Reddy Health City, Suraram, Telangana
•	 Malla Reddy Narayana Multispeciality Hospital, 
Suraram, Telangana.
A prospective and cross-sectional study was carried 
out in the various wards of hospitals. The patients suffering 
from renal compromised state and having infectious 
co-morbid conditions were identified during ward rounds 
by regular case record reviews during the study period. 
The enrolled patients were taken follow-up from the day of 
admission till the day of discharge and the relevant study 
data including laboratory investigations, recent medical 
history of the patient (not more than 1 month) from the 
case record of the patient, and medical history interview 
was documented in case record form.
Study Criteria
Inclusion criteria
Patient population showing either of the following:
•	 Kidney disease state – CKD, AKI, nephropathy, 
nephritis, and obstruction to solitary kidney function.
•	 Patients on dialysis.
•	 Patients with congenital kidney malfunctioning 
state.
•	 Patients with altered kidney functioning (altered 
GFR, altered clearance of metabolites).
•	 Patients having specific infection as co-morbidity.
Exclusion criteria
The following criteria were excluded from the study:
•	 Patients with recent surgical procedures other than 
those related to the kidney.
•	 In clinically indicated for the patient to have LFT 
as a part of pre-assessment for the surgery and this 
screening ALT or ASP is above 3 times the upper 
limit of normal values.
•	 Pregnant and lactating women.
•	 Infants.
Study Duration
The study was conducted for a span of 11 months, starting 
from the month of April 2018 till the end of February 
2019.[11-20]
RESULTS AND DISCUSSION
A total of 195 subjects were analyzed to have renal 
compromised state during the study period. Of these, 
120 subjects were suffering infectious co-morbidity, of 
which 108 subjects were enrolled based on inclusion and 
exclusion criteria, which includes in-patients, out-patients, 
and regular dialysis patients. Of the total of 108 enrolled 
subjects, there were 67 male and 41 female subjects, with 
a mean age value of 54.57 years.
Renal State of Enrolled Subjects
The enrolled 108 subjects based on their renal state 
were classed and analyzed. It was seen that 84 subjects 
were suffering from CKD; 15 subjects from AKI; 4 
subjects from each of nephritis, nephrotic syndrome, 
nephropathy; 3 subjects from hydroureteronephrosis; 
and 2 subjects from each of obstruction in voiding urine 
and ADPKD. In certain cases, subjects were known to 
exhibit multiple renal compromised states [Graph 1 and 
Table 1].
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Graph 1: Graphical representation of renal state of subjects 
enrolled
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Infectious Co-morbid State
The percentage incidence of various infection diagnosed 
in the subject during the study duration was found to 
be: Hepatitis C-virus infection (0.94), septicemia (1.88), 
pulmonary tuberculosis (1.88), upper respiratory tract 
infections (2.83), pleural effusion (6.6), septic shock (6.6), 
urosepsis (8.49), pneumonia (10.37), lower respiratory 
tract infection (LRTI) (16.98), sepsis (20.75), and urinary 
tract infection (22.64) [Graph 2 and Table 2].
The percentage prevalence of septicemia was found 
to be 1.88 during this study, which was closer to 2.2, the 
study results conducted by Allareddy et al. (2017). The 
summative total percentage prevalence of sepsis, septic 
shock, septicemia, and urosepsis was found to be 37.72, 
which was closer to 35% as in the study result which was 
conducted by Dalrymple and Go (2008).
The study has shown that the percentage prevalence 
of pulmonary TB was found to be 1.88, which was 
Table 1: Renal state of subjects enrolled
Renal state Number of 
subjects
ADPKD 2
AKI 15
CKD 84
Hydroureteronephrosis 3
Nephritis 4
Nephropathy 4
Nephrotic syndrome 4
Obstruction in voiding 
urine
2
Table 2: Incidence of infectious co-morbid state
Infectious disease Number of 
subjects
Percentage 
incidence
HCV 1 0.94
Lower respiratory tract 
infections
18 16.98
Pleural effusion 7 6.6
Pneumonia 11 10.37
Sepsis 22 20.75
Septic shock 7 6.6
Septicemia 2 1.88
Pulmonary TB 2 1.88
Upper respiratory tract 
infections
3 2.83
Urinary tract infections 24 22.64
Urosepsis 9 8.49
closer to 2.27 found in the study results conducted by 
Lui et al. (2001). The percentage prevalence of LRTI 
and pneumonia during this study was found to be 16.98 
and 10.37, respectively, which were similar to the study 
results conducted by McDonald et al. (2015) which were 
15.58 and 10.3 for the incidence of LRTI and pneumonia, 
respectively.
In this study, the percentage prevalence of hepatitis 
C virus infection was found to be 0.94, which lies in the 
study range (0.2–3.5) conducted by Cavolia et al. (2011).
Fever State
The state of fever, considering as temperature ≥100° F, 
among the enrolled subjects, was seen in 80 subjects of 
108 subjects (74.07%). Of the 80 subjects, it was found 
that 54 subjects suffered from fever, while 26 subjects 
suffered from fever with chills. The data were classed 
further as fever/fever with chills- within 24 h of dialysis, 
within 48 h of dialysis and unspecified period of time 
[Graph 3 and Table 3].
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infectious co-morbid diseases
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During the study period, 74 subjects (68.51%) were 
confirmed to develop a fever as a post-dialysis outcome. 
According to a study conducted by Kanda (2014), patients 
on hemodialysis may develop a fever as an allergic 
reaction after blood comes into contact with a dialysis 
device as an artificial material. When patients develop 
an allergic symptom such as anaphylactic shock within a 
few minutes after the start of dialysis (type A), substances 
from the dialyzer or bacterial contaminants are considered 
as a cause of the symptom. The symptoms of patients 
with immunoglobulin E antibodies against ethylene 
oxide gas may become serious. Drugs administered to 
dialysis patients, such as anticoagulants, acetate, and 
erythropoietin, may also induce a fever. Mild allergic 
symptoms that occur approximately 30 min after the start 
of dialysis are of type B, which occurs later than type A. 
Type B allergic reactions are considered to result from the 
activation of the complement system after blood comes 
in contact with the dialysis membrane. For example, 
regenerated cellulose membranes used for dialysis tend 
to activate this complement system. Thus, the material 
quality of dialysis membranes has been improved and 
synthetic polymer membranes have been manufactured. 
In addition to the above-mentioned allergic reactions, the 
temperature of the dialysate incorporated into dialysis 
machines may also cause a fever when it is set high.
Contaminants in the dialysate such as endotoxins and 
bacterial components (peptidoglycan) may be absorbed 
into the patient’s body through inverse diffusion or inverse 
filtration through the dialysis membrane and cause a 
fever. Therefore, regular monitoring of the quality of the 
dialysate and the appropriate purification of the dialysate 
is indispensable. Sterilization using ethylene oxide gas 
more frequently induces allergic reactions than γ-ray and 
autoclave sterilizations and requires careful checking.
When the cause of fever is clear, the appropriate 
treatment strategy can be promptly taken. When the 
cause of fever is unclear, however, the diagnosis should 
be started based on the urgency of treatment and Durack 
and Street’s FUO classification. First, the patient’s clinical 
history should be carefully examined. For example, the 
onset time and time course of fever, the place of cause of 
fever (inside or outside the hospital), the use of artificial 
materials (catheters and artificial blood vessels), possible 
factors for the decrease in neutrophil count, and the risk 
of HIV infection should be examined. It is also useful to 
interview the patients about their travel history, living 
environment, the presence or absence of persons they 
are in close contact with a similar symptom, regular 
medication, and pet ownership.
Urine Culture Reports
Urine culture report was prescribed for 29 subjects of 31 
subjects suffering from urosepsis and UTI, during the study 
period to possibly identify the microbial pathogen. The 
data were recorded and analyzed [Graph 4 and Table 4].
During this study, the percentage prevalence of 
various pathogens was found to be: Candida species (3.4), 
Pseudomonas species (13.7), Staphylococcus species 
(13.7), Pneumonia species (17.2), Klebsiella species 
(24.1), and Escherichia coli (27.5).
The percentage prevalence of Pseudomonas 
species (13.7) found in the study was similar to the study 
conducted by Ponce et al. (2007) which was reported 
to be 13.3%. The percentage prevalence of E. coli 
and Klebsiella species was found to be 27.4 and 24.1, 
respectively, during this study, which was closer to 24.4% 
and 22.2% prevalence, as found in the study conducted by 
AbouDagher et al. (2015).
Leukocytes
White blood cells (WBC), also referred to as leukocytes, 
are components of blood, which serves by providing 
immunity against pathogens. High WBC count may 
indicate the presence of certain pathogens and that the 
immune system is working to destroy infection, while 
Table 3: Fever condition in enrolled subjects
Type of fever Number of subjects
Within 
24 h of 
dialysis
Within 
48 h of 
dialysis
Unspecified 
time
Fever 20 28 6
Fever with 
chills
14 4 8
No fever 28
Table 4: Susceptibility of various pathogens in subjects 
prescribed with a urine culture
Culture organism Number of 
subjects
Percentage 
incidence
Candida species 1 3.4
Escherichia coli 8 27.5
Klebsiella species 7 24.1
Pneumonia species 5 17.2
Pseudomonas 
species
4 13.7
Staphylococcus 
species
4 13.7
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Table 6: Levels of CRP in prescribed subjects
Level of CRP (mg/L) Number of 
subjects
0–10.9 15
11.0–20.9 36
21.0–30.9 35
31.0–40.9 12
41.0-50.9 4
50.0–60.9 2
CRP: C-reactive protein
Table 5: Leukocyte (WBC) count in prescribed subjects
WBC count (cells/cumm) Number of 
subjects
0–5000 4
5001–10,000 27
10,001–15,000 27
15,001–20,000 25
20,001–25,000 15
25,001–30,000 7
30,001–35,000 2
35,001–40,000 1
WBC: White blood cells
27.5%
24.1 %
17.2 %
Candida E. coli Klebsiella
Pneumonia Pseudomonas Staphylococcus
13.7 %
3.4 %
13.7 %
Graph 4: Pie-graph representation of microbial pathogens in urine 
culture
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Graph 5: Graphical representation of white blood cells count in 
prescribed subjects
low WBC count signals that an injury or condition is 
destroying cells faster than they are being produced.
Normal count of WBC in a healthy individual ranges 
from 4000 to 11,000 cells/cumm. During this study, the 
WBC count was examined as part of regular CBP check-up 
in all the subjects [Graph 5 and Table 5].
C-reactive Protein (CRP)
CRP is an acute-phase reactant, a protein made by the 
liver and released in the blood within a few hours after 
tissue injury, the start of an infection, or other causes of 
inflammation. The normal range of CRP is 0–10 mg/L. 
During this study, 104 of 108 subjects were prescribed 
for CRP [Graph 6 and Table 6]. It was seen that majority 
of subjects had CRP levels ranging from 11.0 to 
30.9 mg/L.[21-30]
CONCLUSION
This prospective and cross-sectional study revealed that 
the incidence of infectious diseases in patients suffering 
from renal compromised state exists and the probability 
of encountering a subject with renal compromised state 
along with co-morbid infection is 0.55.
0
5
10
15
20
25
30
35
40
0-10.9 11.0-20.9 21.0-30.9 31.0-40.9 41.0-50.9 50.0-60.9
Level of CRP (mg/L)
Number
of 
subjects 
Graph 6: Graphical representation of the level of C-reactive 
protein in prescribed subjects
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The study has shown that male subjects developed 
co-morbid infectious conditions with a prevalence rate of 
about 62.03%, while it was 37.97% in the case of females, 
which reveals that male subjects could attain infectious 
co-morbid state 1.6 times more than the females.
It was seen that of the various subjects that developed 
a fever during the study period, the majority belonged to 
the post-dialysis group (82.5%), which shows possibility 
at contaminants in the dialysate such as endotoxins and 
bacterial components (peptidoglycan) may be absorbed 
into the patient’s body through inverse diffusion or inverse 
filtration through the dialysis membrane and cause fever, 
apart from patient’s specific reasons.
Evidence-based international guidelines are of 
great value and are instrumental in helping reduce health-
care-associated infections. The cornerstone toward 
risk reduction is to be aware and abreast of the latest 
guidelines and be keen on implementing them reliably 
and consistently, as well as being conscientious and 
alert/active in engaging in quality improvement projects. 
The decision to follow any guideline statement must be 
made individually by each HD unit at different locations 
with varying conditions, according to the incidence and 
prevalence of any type of infection. However, the patient’s 
safety and well-being deserve top priority in whatever 
decision is to be made.[31-34]
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